Has Adolfo Garcia, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,172 in general payments to Adolfo Garcia, MD across 53 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Adolfo Garcia, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Adolfo Garcia, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Adolfo Garcia, MD

Nephrology · Laredo, TXNPI 1194723775

Payments from drug & device makers

$1,172in general payments, 2019–2025

Across 53 payments — averaging $22.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Vifor Pharma, Inc.$375
AstraZeneca$279
Amgen$167
Aurinia Pharma U.S., Inc.$141
Bayer$100
Baxter Healthcare$93
plus $16 from 1 others

What the payments were for

Food & beverage$1,03989%
Education$403%
Other$938%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Vifor Pharma, Inc.	31	$375
AstraZeneca	7	$279
Amgen(2 entities)	4	$167
Aurinia Pharma U.S., Inc.	8	$141
Bayer	1	$100
Baxter Healthcare	1	$93
Mallinckrodt Enterprises LLC	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

FARXIGA$106

How this compares

$1,172 in reported general payments places this provider in the 40th percentile of 1,070 nephrology providers in Texas.

See all nephrology providers in Texas →

Medicare billing

Part B allowed, 2024

$11,322

Medicare patients

Services billed

119

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Nifedipine ErNifedipine	26	$1,517
Cinacalcet Hcl	17	$1,060
Calcium Acetate	14	$949
Losartan Potassium	13	$70
Atorvastatin Calcium	14	$69
Prednisone	19	$68
Furosemide	16	$65
Metoprolol Tartrate	28	$59
Metoclopramide Hcl	12	$40
Allopurinol	14	$36
Omeprazole	11	$23

Paid to pharmacies, not to this prescriber.

Other nephrology in Laredo

Pablo PergolaSan Antonio$14.2M
German HernandezEl Paso$9.7M
Sreedhar MandayamHouston$7M
Tahira AlvesSan Antonio$6.1M
Carl DukesSan Antonio$5.9M
Chinonye Ogbonnaya-OdorSan Antonio$4.6M
Marializa BernardoHouston$4.2M
Judith BettsAustin$3.7M
Wesley CalhounSan Antonio$3.5M
Adam FromeThe Woodlands$3.1M

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →